Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-23-000013 General Corporate
Debt relative to revenue 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
166.96% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.70% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.75% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
15.60% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
77.46% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.85% · CORE · VALID
Operating margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.01% · CORE · VALID
R&D intensity 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.87% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 194.91%
Current 166.96%
Delta -27.95% Capex Intensity Increased
Previous 1.69%
Current 1.70%
Delta 0.01% Cash Generation Increased
Previous -14.52%
Current 15.75%
Delta 30.27% Growth Increased
Previous 12.76%
Current 15.60%
Delta 2.83% Inventory Pressure Decreased
Previous 83.69%
Current 77.46%
Delta -6.23% Margin Increased
Previous 35.10%
Current 36.85%
Delta 1.75% Profitability Increased
Previous 12.46%
Current 16.01%
Delta 3.55% R And D Intensity Decreased
Previous 3.49%
Current 2.87%
Delta -0.62% Sbc Intensity Decreased
Previous 0.82%
Current 0.52%
Delta -0.30% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.